MSD SHARP & DOHME GmbH
- Pharmaceutical Sales 2009
-
worldwide: 27.4 billion US $
in Germany: 666.5 million EUR
- Product Range
- Type 2 diabetes, osteoarthritis, osteoporosis, HIV/AIDS, hypertension, asthma, androgenetic alopecia, migraine, ophthalmopathy, nausea and vomiting with chemotherapy, metabolic disorders e.g. hypercholesterolemia, bacterial infections, fungal infections
- Key Research Areas
- research laboratories worldwide with more than 7.800 employees: Atherosclerosis, Cardiovascular Disease, Diabetes, Vaccines, Oncology, Neurology, Ophthalmology, Women's Health and Fertility, Infectious Diseases, Osteoporosis, Immunology, Respiratory Diseases
- R&D Expenditure 2009
-
worldwide: 5.8 billion US $
in Germany: 20.6 million EUR
- Employees in the Pharmaceuticals Division 2009
-
Worldwide: 100,000
Germany: 1,200
(All data based on corporate information, as of: 06/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page